Suppr超能文献

急性胰腺炎与新型冠状病毒肺炎:文献综述

Acute pancreatitis and COVID-19: A literature review.

作者信息

Correia de Sá Tiago, Soares Carlos, Rocha Mónica

机构信息

Department of General Surgery, Centro Hospitalar do Tâmega e Sousa, Penafiel 4564-007, Portugal.

出版信息

World J Gastrointest Surg. 2021 Jun 27;13(6):574-584. doi: 10.4240/wjgs.v13.i6.574.

Abstract

BACKGROUND

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing pandemic of coronavirus disease 2019 (COVID-19), and has caused more than 80 million infections and 1.7 million deaths worldwide. Although it is primarily a respiratory virus, SARS-CoV-2 also has extra-pulmonary effects. Pancreatic injury and cases of acute pancreatitis (AP) have been recognized and attributed to SARS-CoV-2, but the mechanisms of pancreatic injury are still a subject of debate. There is also controversy on whether SARS-CoV-2 can cause AP or if it is an epiphenomenon.

AIM

To review and to explore the relationship between SARS-CoV-2 infection and AP, and to provide an overview of the existing literature on possible mechanisms of SARS-CoV-2-induced pancreatic lesion.

METHODS

A systematic review was conducted in accordance with PRISMA guidelines for papers on SARS-CoV-2 infection and AP. A narrative review on possible mechanisms of SARS-CoV-2-induced pancreatic lesion was also performed.

RESULTS

A literature review revealed a growing body of evidence on SARS-CoV-2-induced pancreatic lesions including the mechanisms of direct virus-mediated injury, systemic inflammatory response and circulating pro-inflammatory interleukins, virus-induced lipotoxicity, and drug-induced injury. A systematic review of the literature revealed 22 cases of AP in COVID-19 patients. However, limitations of the reported cases make it difficult to establish a causal relationship between SARS-CoV-2 infection and AP. All of the studies agreed on special monitoring and surveillance of this subset of patients due to the still unknown clinical progression, therapeutic implications, and prognosis.

CONCLUSION

AP should be considered in COVID-19 patients, especially in those exhibiting abdominal pain and systematic, and complete reporting of these cases should be general practice. However, there is still insufficient evidence showing that COVID-19 can cause AP or negatively impact prognosis. Additional studies are needed to clarify the relationship between these two entities and their theragnostic significance.

摘要

背景

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)导致了2019冠状病毒病(COVID-19)的持续大流行,在全球已造成超过8000万例感染和170万人死亡。尽管SARS-CoV-2主要是一种呼吸道病毒,但它也有肺外效应。胰腺损伤和急性胰腺炎(AP)病例已被确认并归因于SARS-CoV-2,但胰腺损伤的机制仍是一个有争议的话题。关于SARS-CoV-2是否能引起AP或它是否只是一种附带现象也存在争议。

目的

回顾并探讨SARS-CoV-2感染与AP之间的关系,并概述关于SARS-CoV-2诱导胰腺病变可能机制的现有文献。

方法

根据PRISMA指南对关于SARS-CoV-2感染和AP的论文进行系统综述。还对SARS-CoV-2诱导胰腺病变的可能机制进行了叙述性综述。

结果

文献综述显示,关于SARS-CoV-2诱导胰腺病变的证据越来越多,包括直接病毒介导的损伤机制、全身炎症反应和循环促炎细胞因子、病毒诱导的脂毒性以及药物诱导的损伤。对文献的系统综述发现COVID-19患者中有22例AP病例。然而,报告病例的局限性使得难以确定SARS-CoV-2感染与AP之间的因果关系。由于临床进展、治疗意义和预后仍不清楚,所有研究都一致认为应对这一亚组患者进行特殊监测和观察。

结论

COVID-19患者应考虑并发AP,尤其是那些出现腹痛的患者,并且对这些病例进行全面完整的报告应成为常规做法。然而,仍没有足够的证据表明COVID-19可导致AP或对预后产生负面影响。需要更多的研究来阐明这两个实体之间的关系及其诊疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89e/8223706/00763bf9bc65/WJGS-13-574-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验